About Contact Us Careers
Sign In

Genome Editing Market Size & Share, by Application (Cell Line Engineering, Genetic Engineering, Drug Discovery, Gene-modified Cell Therapy, Diagnostics); End-user (Academics & Government Institutes, Biotechnology & Pharma Companies, Hospitals); Technology (CRISPR, TALEN, ZFN); Delivery (In-vivo, Ex-vivo) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 4807
  • Published Date: Oct 03, 2023
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Global Genome Editing Market

top-features-companies
    • Thermo Fisher Scientific Inc. 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Horizon Discovery Ltd.
    • Lonza Group Ltd.
    • Twist Bioscience Corporation 
    • Akron Biotech.
    • CRISPR Therapeutics
    • Sangamo Therapeutics
    • Editas MedicineIntellia Therapeutics, Inc. 
Browse Key Market Insights with Data Illustration:

In the News

  • Merck acquired AmpTec, a Hamburg-based mRNA contract development and manufacturing organization (CDMO).
  • Gibco CTS TrueCut Cas9 Protein enables genome editing for research and manufacturing, including CAR T-cell therapy.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4807
  • Published Date: Oct 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Prevalence of cancer worldwide, increased spending on healthcare and rising awareness owing to research are some of the major growth factors for the Genome Editing Market.

The market size of Genome Editing is anticipated to attain a CAGR of 21.1% over the forecast period, i.e., 2024 – 2036.

The major players in the market are Merck KGaA, Horizon Discovery Ltd., Lonza Group Ltd.,Twist Bioscience Corporation ,Akron Biotech., CRISPR Therapeutics, Sangamo Therapeutics,Editas Medicine, Intellia Therapeutics, Inc.,Setsuro Tech Inc. and others

The genetic engineering segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying